MIR5692B

Across TCGA pan-cancer cohorts, MIR5692B RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated MIR5692B data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher MIR5692B RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR5692B expression acts as an unfavorable survival marker, although some lineages such as MESO show a favorable association.

CESC, CHOL, and READ are the cancer types where MIR5692B RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Tertile	All	0.739	0.890	.003	54	view →
CHOL	OS	Tertile	All	0.420	0.876	.006	51	view →
READ	DFS	Tertile	All	0.446	0.807	.003	33	view →
LIHC	DFS	Tertile	III,IV	0.259	0.450	.017	27	view →
SARC	OS	Tertile	All	0.126	0.867	<.001	24	view →
LUAD	DFS	Quartile	IV	0.511	0.978	<.001	22	view →
LUSC	DFS	Tertile	III,IV	0.385	0.676	.008	18	view →
THCA	OS	Tertile	IV	0.531	0.924	.003	14	view →
MESO	DFS	Tertile	All	1.000	0.193	.036	6	view →
STAD	DFS	Quartile	II,III,IV	0.497	0.649	.025	5	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

MIR5692B–CESC (OS)

Open the CESC breakdown →